Perbedaan Humpuss Maritim Internasional Tbk. dan Indofarma Tbk.: Humpuss Maritim Internasional Tbk. diperdagangkan di Rp137 (kapitalisasi pasar 2,47 T, volume 24 jam 40,18 jt), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: Humpuss Maritim Internasional Tbk. jauh lebih besar — sekitar 6,3× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| HUMI | INAF | |
|---|---|---|
Kapitalisasi Pasar | 2,47 T | 390,51 M |
Volume | 40,18 jt | — |
Lot | 401,82 rb | — |
Perputaran | 5,4 M | — |
Harga Rata-rata | 134,5 | — |
Nilai Transaksi | 5,4 M | — |
Harga Ekuilibrium Indikatif | 137 | — |
Volume Ekuilibrium Indikatif | 13,29 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Humpuss Maritim Internasional Tbk. (the Company) is a limited liability company incorporated under the laws of the Republic of Indonesia by virtue of Notarial Deed No. 21 dated September 29, 2016 of Martina, S.H., Notary in Jakarta. The Company change its name from PT MISI Hutama Internasional to PT Humpuss Maritim Internasional. The Company has started its commercial operation since December 2016. Parent entity ofthe Company is PT Humpuss Transportasi Kimia and ultimate parent of the Company is PT Humpuss Intermoda Transportasi Tbk. The Company’s controlling party is H. Hutomo Mandala Putra, SH.
Selengkapnya di halaman HUMI →PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →